Quoin Pharmaceuticals, Ltd. American Depositary Shares

QNRXNASDAQUSD
5.57 USD
0.58 (11.62%)AT CLOSE (11:59 AM EDT)
5.50
0.07 (1.26%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
5.50
0.07 (1.26%)
🔴Market: CLOSED

QNRX is currently priced at $5.57. QNRX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 21, 2026.

Open?$5.29
High?$5.88
Low?$5.02
Prev. Close?$4.99
Volume?72.1K
Avg. Volume?19.7K
VWAP?$5.37
Rel. Volume?3.67x
Bid / Ask
Bid?$5.26 × 100
Ask?$5.74 × 100
Spread?$0.48
Midpoint?$5.50
Valuation & Ratios
Market Cap?11.2M
Shares Out?2.0M
P/E Ratio?N/A
P/B Ratio?1.28
EPS?-$8.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
11.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
38
Piotroski F-Score?0/9Weak
Altman Z-Score?-8.72Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short Interest?115.8K
Days to Cover?10.7
Avg Daily Volume10.8K
Settlement Date2026-07-31
Financial Health
Current Ratio?2.87Strong
Quick Ratio?2.87Strong
Cash Ratio?0.58Adequate
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
92
1.28CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.5CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-193.7%WEAK
ROA?
S&P
3
-108.3%WEAK
Cash Flow & Enterprise
FCF?$-15815738
Enterprise Value?$9.2M
Fundamentals ratios updated end of day